BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12686681)

  • 1. BK transplant nephropathy successfully treated with cidofovir.
    Keller LS; Peh CA; Nolan J; Bannister KM; Clarkson AR; Faull RJ
    Nephrol Dial Transplant; 2003 May; 18(5):1013-4. PubMed ID: 12686681
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient.
    Bjorang O; Tveitan H; Midtvedt K; Broch LU; Scott H; Andresen PA
    Nephrol Dial Transplant; 2002 Nov; 17(11):2023-5. PubMed ID: 12401867
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnosis of interstitial nephropathy caused by BK virus in renal transplantation. Therapeutic management with cidofovir plus probenecid].
    Barrios C; Puig JM; Mir ML
    Nefrologia; 2007; 27(6):774-5. PubMed ID: 18336115
    [No Abstract]   [Full Text] [Related]  

  • 4. BK nephropathy: what is the role of antiviral therapy?
    Fishman JA
    Am J Transplant; 2003 Feb; 3(2):99-100. PubMed ID: 12614295
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic possibilities for polyomavirus infections in renal transplantation].
    Hurault de Ligny B; Godin M; Lobbedez T; Etienne I; El Haggan W; Pujo M; Ryckelynck JP
    Presse Med; 2003 Apr; 32(14):667-8. PubMed ID: 12714908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cidofovir in polyomavirus BK viral nephropathy in two renal allograft recipients.
    Lim WH; Mathew TH; Cooper JE; Bowden S; Russ GR
    Nephrology (Carlton); 2003 Dec; 8(6):318-23. PubMed ID: 15012704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy.
    Araya CE; Lew JF; Fennell RS; Neiberger RE; Dharnidharka VR
    Pediatr Transplant; 2006 Feb; 10(1):32-7. PubMed ID: 16499584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation.
    Cabello V; Margarit N; Díaz Pedrero M; Bernal G; Pereira P; Gentil MA
    Transplant Proc; 2008 Nov; 40(9):2930-2. PubMed ID: 19010151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of refractory BK virus-associated nephropathy with cidofovir.
    Kadambi PV; Josephson MA; Williams J; Corey L; Jerome KR; Meehan SM; Limaye AP
    Am J Transplant; 2003 Feb; 3(2):186-91. PubMed ID: 12614296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients.
    Kuypers DR; Bammens B; Claes K; Evenepoel P; Lerut E; Vanrenterghem Y
    J Antimicrob Chemother; 2009 Feb; 63(2):417-9. PubMed ID: 19056749
    [No Abstract]   [Full Text] [Related]  

  • 11. Cidofovir may be deleterious in BK virus-associated nephropathy.
    Hakeem A; Sharma H; Sharma A
    Transplantation; 2011 Jan; 91(2):e11-2; author reply e12. PubMed ID: 21239956
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults.
    Vats A; Shapiro R; Singh Randhawa P; Scantlebury V; Tuzuner A; Saxena M; Moritz ML; Beattie TJ; Gonwa T; Green MD; Ellis D
    Transplantation; 2003 Jan; 75(1):105-12. PubMed ID: 12544881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of cidofovir treatment of polyomavirus nephropathy in kidney transplant recipients.
    Hua DK; Howard K; Craig JC; Chapman JR; Wong G
    Transplantation; 2012 Jan; 93(2):188-94. PubMed ID: 22186937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [BK virus-associated nephropathy].
    Kaltenis P
    Medicina (Kaunas); 2003; 39(7):637-9. PubMed ID: 12878816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesicular cidofovir for BK hemorrhagic cystitis in pediatric patients after hematopoietic stem cell transplant.
    Foster JH; Cheng WS; Nguyen NY; Krance R; Martinez C
    Pediatr Transplant; 2018 May; 22(3):e13141. PubMed ID: 29388318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cidofovir may be deleterious in BK virus-associated nephropathy.
    Pallet N; Burgard M; Quamouss O; Rabant M; Bererhi L; Martinez F; Thervet E; Anglicheau D; Noel LH; Rouzioux C; Legendre C
    Transplantation; 2010 Jun; 89(12):1542-4. PubMed ID: 20559110
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients.
    Kuypers DR; Vandooren AK; Lerut E; Evenepoel P; Claes K; Snoeck R; Naesens L; Vanrenterghem Y
    Am J Transplant; 2005 Aug; 5(8):1997-2004. PubMed ID: 15996251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful pregnancy in renal transplant recipient with previous known polyomavirus nephropathy.
    Midtvedt K; Bjorang O; Letting AS
    Clin Transplant; 2007; 21(4):571-3. PubMed ID: 17645722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BK virus-associated nephropathy in a kidney transplant recipient successfully treated with cidofovir, the first case in Japan.
    Akioka K; Okamoto M; Ushigome H; Nobori S; Kaihara S; Yoshimura N
    Int J Urol; 2008 Apr; 15(4):369-71. PubMed ID: 18380832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observations on the use of cidofovir for BK virus infection in renal transplantation.
    Kuten SA; Patel SJ; Knight RJ; Gaber LW; DeVos JM; Gaber AO
    Transpl Infect Dis; 2014 Dec; 16(6):975-83. PubMed ID: 25412701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.